Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)

Completed · Not applicable

Conditions studied: Diabetes Mellitus, Type 2

In brief

A Study to assess if patients with Type 2 diabetes (T2D) who have suboptimal glycemic control using multiple oral agents are able to make lifestyle changes resulting in improved glycemic control by use of real-time continuous glucose monitoring (RT-CGM) and targeted learning modules versus self monitored blood glucose (SMBG) testing.

Key facts

Study ID

NCT03620357

Run by

DexCom, Inc.

People needed

72

Starts

2018-09-05

Expected to finish

2020-11-04

Last updated by the study team

2021-03-22

Who can join

Age: 30 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Diabetes/Lipid Management and Research Center — Huntington Beach, California, United States
• Temecula Valley Endocrinology — Temecula, California, United States
• Atlanta Diabetes Associates — Atlanta, Georgia, United States
• MODEL Clinical Research (Towson) — Baltimore, Maryland, United States
• Diabetes & Endocrine Associates, PC — Omaha, Nebraska, United States
• Las Vegas Endocrinology — Henderson, Nevada, United States
• The Docs — Las Vegas, Nevada, United States
• Palm Research Center — Las Vegas, Nevada, United States
• Diabetes and Glandular Disease Clinic — San Antonio, Texas, United States
• LMC Manna Research — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.